1-8 of 8
Lukas Bubendorf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

Solange Peters, Rolf Stahel, Lukas Bubendorf, Philip Bonomi, Augusto Villegas, Dariusz M. Kowalski, Christina S. Baik, Dolores Isla, Javier De Castro Carpeno, Pilar Garrido, Achim Rittmeyer, Marcello Tiseo, Christoph Meyenberg, Sanne de Haas, Lisa H. Lam, Michael W. Lu, Thomas E. Stinchcombe
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 64–72.
https://doi.org/10.1158/1078-0432.CCR-18-1590
Published: 03 January 2019
View article titled, Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers
Open the PDF for Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers in another window
Includes: Supplementary data
Journal Articles

Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer

Clémentine Le Magnen, Lukas Bubendorf, Cyrill A. Rentsch, Chantal Mengus, Joel Gsponer, Tobias Zellweger, Malte Rieken, George N. Thalmann, Marco G. Cecchini, Markus Germann, Alexander Bachmann, Stephen Wyler, Michael Heberer, Giulio C. Spagnoli
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19): 5361–5371.
https://doi.org/10.1158/1078-0432.CCR-12-2857
Published: 01 October 2013
View article titled, Characterization and Clinical Relevance of ALDH<sup>bright</sup> Populations in Prostate Cancer
Open the PDF for Characterization and Clinical Relevance of ALDH<sup>bright</sup> Populations in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07)

Richard Cathomas, Christian Rothermundt, Dirk Klingbiel, Lukas Bubendorf, Rolf Jaggi, Daniel C. Betticher, Peter Brauchli, Denise Cotting, Cornelia Droege, Ralph Winterhalder, Daniele Siciliano, Dominik R. Berthold, Miklos Pless, Ralph Schiess, Roger von Moos, Silke Gillessen, for the Swiss Group for Clinical Cancer Research (SAKK)
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (21): 6049–6057.
https://doi.org/10.1158/1078-0432.CCR-12-2219
Published: 06 November 2012
View article titled, Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07)
Open the PDF for Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07) in another window
Journal Articles

Expression of Voltage-Gated Potassium Channels in Human and Mouse Colonic Carcinoma

Jiraporn Ousingsawat, Melanie Spitzner, Supaporn Puntheeranurak, Luigi Terracciano, Luigi Tornillo, Lukas Bubendorf, Karl Kunzelmann, Rainer Schreiber
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (3): 824–831.
https://doi.org/10.1158/1078-0432.CCR-06-1940
Published: 08 February 2007
View article titled, Expression of Voltage-Gated Potassium Channels in Human and Mouse Colonic Carcinoma
Open the PDF for Expression of Voltage-Gated Potassium Channels in Human and Mouse Colonic Carcinoma in another window
Journal Articles

Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence

Hongzhen Li, Ying Zhang, Andrew Glass, Tobias Zellweger, Edmund Gehan, Lukas Bubendorf, Edward P. Gelmann, Marja T. Nevalainen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 5863–5868.
https://doi.org/10.1158/1078-0432.CCR-05-0562
Published: 22 August 2005
View article titled, Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence
Open the PDF for Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence in another window
Journal Articles

Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients

Meera Srivastava, Lukas Bubendorf, Mark Raffeld, Christoph Bucher, Jochen Torhorst, Guido Sauter, Cara Olsen, Olli P. Kallioniemi, Ofer Eidelman, Harvey B. Pollard
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (7): 2344–2350.
https://doi.org/10.1158/1078-0432.CCR-03-0278
Published: 08 April 2004
View article titled, Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients
Open the PDF for Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients in another window
Journal Articles

Elevated Expression of Inhibitor of Apoptosis Proteins in Prostate Cancer

Maryla Krajewska, Stan Krajewski, Steven Banares, Xianshu Huang, Bruce Turner, Lukas Bubendorf, Olli-P. Kallioniemi, Ahmed Shabaik, Antonella Vitiello, Donna Peehl, Guo-Jian Gao, John C. Reed
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (13): 4914–4925.
Published: 27 October 2003
View article titled, Elevated Expression of Inhibitor of Apoptosis Proteins in Prostate Cancer
Open the PDF for Elevated Expression of Inhibitor of Apoptosis Proteins in Prostate Cancer in another window
Journal Articles

Tissue Microarrays for Gene Amplification Surveys in Many Different Tumor Types

Peter Schraml, Juha Kononen, Lukas Bubendorf, Holger Moch, Heidi Bissig, Antonio Nocito, Michael J. Mihatsch, Olli-P. Kallioniemi, Guido Sauter
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 1966–1975.
Published: 01 August 1999
View article titled, Tissue Microarrays for Gene Amplification Surveys in Many Different Tumor Types
Open the PDF for Tissue Microarrays for Gene Amplification Surveys in Many Different Tumor Types in another window